Background The role of corticosteroids in the treatment of community-acquired pneumonia
(CAP) remains uncertain. We conducted an updated meta-analysis to investigate the …

Background Corticosteroids are an option in the treatment of community-acquired
pneumonia (CAP). However, the benefits and adverse effects of corticosteroids, especially in …

Background The benefit of corticosteroids in community-acquired pneumonia (CAP) remains
controversial. We did a meta-analysis to include all the randomized controlled trials (RCTs) …

Background Community-acquired pneumonia (CAP) is associated with high morbidity and
mortality. In the present study, we aimed to assess the effect of corticosteroids on all-cause …

Background: The systemic use of corticosteroids for patients in severe community-acquired
pneumonia (CAP) remains disputed in clinical practice. We undertook a systematic review …

The objective of this study was to systematically evaluate the clinical efficacy of the
complementary use of corticosteroids in the treatment of community-acquired pneumonia …

Background Our aim was to evaluate the benefits and harms of adjunctive corticosteroids in
adults hospitalized with community-acquired pneumonia (CAP) using individual patient data …

Background Adjunctive corticosteroids therapy is an attractive option for community-
acquired pneumonia (CAP) treatment. However, the effectiveness of adjunctive …

Background Community-acquired pneumonia (CAP) is a leading cause of morbidity and
mortality. Corticosteroids may be a beneficial adjunct in the treatment of bacterial …

BACKGROUND: The debate about the efficacy of corticosteroids in the treatment of severe
community-acquired pneumonia (CAP) is still a longstanding dilemma. We performed a …